All PlansCoverageMedium impact
Irreversible Electroporation of Tumors Located in the Liver, Pancreas, Kidney, Lung, or Prostate
Blue Cross & Blue Shield of Mississippi·MS · Oncology, General Surgery, Urology +3 more·Medical Policy
We identified it
Jun 20, 2026
Summary
BCBSMS has updated their medical policy on Irreversible Electroporation (IRE) for tumor treatment in liver, pancreas, kidney, lung, and prostate. The policy provides detailed coverage criteria and clinical background for this specialized ablation technique that uses electric pulses to destroy cancer cells without thermal damage.
Action Required
Review the updated IRE policy to understand coverage criteria for tumor ablation procedures in liver, pancreas, kidney, lung, and prostate. Ensure documentation supports medical necessity when submitting claims for IRE procedures, particularly noting the policy's emphasis on cases where patients are not candidates for surgery or traditional thermal ablation methods.